This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Proleukin

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Proleukin Means in Everyday Medical Language

Proleukin is a medicine made in a laboratory that acts like a natural protein in your body called interleukin-2 (IL-2). IL-2 is part of your immune system and helps certain white blood cells, especially T cells and B cells, grow and become more active. These cells help your body fight infections and some cancers. Proleukin is used to boost your immune system’s ability to attack cancer cells by increasing the activity and growth of these immune cells.

Why Proleukin Can Matter in Cancer Care

Proleukin is important because it offers a way to help your body’s natural defenses work harder against cancer. It is approved for adults with melanoma, a serious skin cancer, and renal cell carcinoma, a type of kidney cancer, especially when these cancers have spread beyond their original location. By increasing immune activity, Proleukin may help slow cancer growth or shrink tumors in some patients. Researchers are also studying it for other cancers to see if it can help more people in the future.

What Patients Might See or Hear About Proleukin

You might come across the term Proleukin in your treatment plan, on a medication list, or in notes from your doctor or nurse. It could also be mentioned when discussing clinical trials, which are research studies testing new ways to treat cancer. Hearing about Proleukin does not mean it will be used for everyone or that it is a cure. It is one option among many and may be combined with other treatments or used in research settings. The names Aldesleukin and recombinant human interleukin-2 refer to the same medicine, so seeing different names does not mean different drugs.

Common Confusions and Related Terms

Proleukin is sometimes called Aldesleukin or recombinant human interleukin-2. These names all refer to the same drug. It is a type of cytokine, which is a natural messenger in the immune system. This is different from chemotherapy or radiation, which directly attack cancer cells. Understanding that Proleukin works by boosting certain white blood cells can help clarify how it fits into cancer treatment. It is not the same as other immune therapies that work differently.

Practical Questions to Ask Your Healthcare Team

If Proleukin is part of your care, helpful questions include: How does this drug work with my specific cancer? What side effects should I expect, and how can they be managed? Are there other treatments that might work better for me? Is Proleukin part of a clinical trial, and what does that mean for my care? Talking openly with your care team can help you understand what to expect and feel more involved in decisions.

How to Read the Term in Context

Seeing Proleukin in your medical records or treatment plan means it is a medicine designed to help your immune system rather than directly attacking cancer cells like some other drugs. Its presence is about exploring possible treatments and does not by itself mean a diagnosis or guarantee a specific outcome. Always ask your care team what it means for your individual situation.

Safety and Next Steps

This information is meant to educate and does not decide what is safe or appropriate for any individual patient. If you see the term Proleukin in your medical records or hear it mentioned, the best next step is to ask your healthcare team to explain how it applies to your care. They can provide details about why it might be recommended, what to expect, and how it fits with other treatments you may be receiving.

Sources

Public source information used for this glossary entry includes: